Atractylenolide III for central nervous system disorders: a review of multi-target mechanisms and therapeutic potential.

Saved in:
Bibliographic Details
Title: Atractylenolide III for central nervous system disorders: a review of multi-target mechanisms and therapeutic potential.
Authors: Li H; Shenzhen Bao'an Chinese Medicine Hospital, The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, China.; Shenzhen Key Laboratory of Metabolic Health, Shenzhen Metabolism and Reproductive Targeted Delivery Proof-of-Concept Center, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China., Zeng NX; Medical Research Center, Dalang Hospital of Dongguan, Dongguan, China., Ge L; Shenzhen Key Laboratory of Metabolic Health, Shenzhen Metabolism and Reproductive Targeted Delivery Proof-of-Concept Center, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China., Ye RL; Medical Research Center, Dalang Hospital of Dongguan, Dongguan, China., Zhuang YY; Shenzhen Bao'an Chinese Medicine Hospital, The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, China., Huang XN; Medical Research Center, Dalang Hospital of Dongguan, Dongguan, China., Liang Q; Shenzhen Bao'an Chinese Medicine Hospital, The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, China., Zhang JV; Shenzhen Key Laboratory of Metabolic Health, Shenzhen Metabolism and Reproductive Targeted Delivery Proof-of-Concept Center, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China., Zhou P; Shenzhen Bao'an Chinese Medicine Hospital, The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, China.
Source: Frontiers in pharmacology [Front Pharmacol] 2026 May 29; Vol. 17, pp. 1799976. Date of Electronic Publication: 2026 May 29 (Print Publication: 2026).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42292848
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Atractylenolide III for central nervous system disorders: a review of multi-target mechanisms and therapeutic potential.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; Shenzhen Bao'an Chinese Medicine Hospital, The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, China.; Shenzhen Key Laboratory of Metabolic Health, Shenzhen Metabolism and Reproductive Targeted Delivery Proof-of-Concept Center, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.<br /><searchLink fieldCode="AU" term="%22Zeng+NX%22">Zeng NX</searchLink>; Medical Research Center, Dalang Hospital of Dongguan, Dongguan, China.<br /><searchLink fieldCode="AU" term="%22Ge+L%22">Ge L</searchLink>; Shenzhen Key Laboratory of Metabolic Health, Shenzhen Metabolism and Reproductive Targeted Delivery Proof-of-Concept Center, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.<br /><searchLink fieldCode="AU" term="%22Ye+RL%22">Ye RL</searchLink>; Medical Research Center, Dalang Hospital of Dongguan, Dongguan, China.<br /><searchLink fieldCode="AU" term="%22Zhuang+YY%22">Zhuang YY</searchLink>; Shenzhen Bao'an Chinese Medicine Hospital, The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, China.<br /><searchLink fieldCode="AU" term="%22Huang+XN%22">Huang XN</searchLink>; Medical Research Center, Dalang Hospital of Dongguan, Dongguan, China.<br /><searchLink fieldCode="AU" term="%22Liang+Q%22">Liang Q</searchLink>; Shenzhen Bao'an Chinese Medicine Hospital, The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, China.<br /><searchLink fieldCode="AU" term="%22Zhang+JV%22">Zhang JV</searchLink>; Shenzhen Key Laboratory of Metabolic Health, Shenzhen Metabolism and Reproductive Targeted Delivery Proof-of-Concept Center, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.<br /><searchLink fieldCode="AU" term="%22Zhou+P%22">Zhou P</searchLink>; Shenzhen Bao'an Chinese Medicine Hospital, The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2026 May 29; Vol. 17, pp. 1799976. <i>Date of Electronic Publication: </i>2026 May 29 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42292848
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2026.1799976
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1799976
    Titles:
      – TitleFull: Atractylenolide III for central nervous system disorders: a review of multi-target mechanisms and therapeutic potential.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Li H
      – PersonEntity:
          Name:
            NameFull: Zeng NX
      – PersonEntity:
          Name:
            NameFull: Ge L
      – PersonEntity:
          Name:
            NameFull: Ye RL
      – PersonEntity:
          Name:
            NameFull: Zhuang YY
      – PersonEntity:
          Name:
            NameFull: Huang XN
      – PersonEntity:
          Name:
            NameFull: Liang Q
      – PersonEntity:
          Name:
            NameFull: Zhang JV
      – PersonEntity:
          Name:
            NameFull: Zhou P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 05
              Text: 2026 May 29
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1